Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
Mesoblast shares fell -4.45% in the first hour of trades on Tuesday as the company announced it has to resubmit an application to the FDA.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CLD | Ann: Units on Issue Disclosure - June 2024 | 04/07/24 | 0 | 61 | |||
|
|||||||
CLD | Ann: Estimated Distribution Announcement | 27/06/24 | 0 | 66 | |||
|
|||||||
CLD | Ann: Distribution Timetable | 24/06/24 | 0 | 92 | |||
|
|||||||
CLD | Ann: Units on Issue Disclosure - May 2024 | 07/06/24 | 0 | 96 | |||
|
|||||||
CLD | Ann: Units on Issue Disclosure - April 2024 | 06/05/24 | 0 | 84 | |||
|
|||||||
CLD | Ann: Units on Issue Disclosure - March 2024 | 05/04/24 | 0 | 121 | |||
|
|||||||
CLD | Ann: Interim Financial Report | 14/03/24 | 0 | 108 | |||
|
|||||||
CLD | Ann: Units on Issue Disclosure - February 2024 | 06/03/24 | 0 | 127 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |